Business Context and Reporting Period
This Form 6-K filing by SMX (Security Matters) Public Limited Company covers the month of July 2024, with the report dated July 9, 2024. The company is a foreign private issuer based in Dublin, Ireland, focusing on security matters and PCR material marking technologies.
Key Financial Metrics and Transactions
- Debt Financing: The company issued a promissory note with a principal amount of $750,000 to Canterbury Group Ltd. Gross proceeds were approximately $615,000 after an original issue discount. The note matures on September 2, 2024.
- Interest and Fees: A one-time interest charge of $24,657.53 was applied at issuance. In the event of default, the repayment obligation increases to 150% of the outstanding principal and accrued interest.
- Equity and Warrants: The financing included warrants for 8,653,846 ordinary shares at an exercise price of $0.10, exercisable until December 31, 2025. Additionally, 67,500 5-year warrants were issued to a former debtholder at an exercise price of $0.0022.
- Debt Settlement: The company issued 4,070,403 ordinary shares (pre-reverse split) to settle liabilities totaling $110,000 USD and AUD 859,500 owed to former debtholders.
- Liquidity and Cash Flow: The filing does not provide specific cash flow statements, balance sheet totals, or revenue figures. Proceeds from the note are designated for working capital and general corporate purposes.
Material Changes and Adjustments
- Anti-Dilution Adjustments: As a result of the new financing, the exercise prices of certain existing warrants and securities held by investors with price-based anti-dilution protection were automatically adjusted downward to $0.10.
- Liability Reduction: The conversion of debt into equity reduced the company's outstanding liabilities by approximately $110,000 USD and AUD 859,500.
- Shareholder Agreements: A Shareholder Voting Agreement was entered into with former debtholders as part of the debt-for-equity exchange.
Outlook, Risks, and Management Commentary
- Strategic Collaboration: On July 9, 2024, the company announced a collaboration with Tradepro Inc. to complete semi-industrial testing for the marking of PCR materials.
- Default Risks: The promissory note contains strict default provisions. Failure to deliver shares upon conversion triggers a "Fail to Deliver Fee" of $1,000 per day. An Event of Default accelerates the debt and increases the repayment obligation to 150% of the principal and interest.
- Regulatory Status: The securities issued in this transaction were not registered under the Securities Act of 1933 and are subject to resale restrictions.
Investor Verification Checklist
- Verify the company's ability to repay the $750,000 principal plus interest by the September 2, 2024 maturity date.
- Confirm the impact of the downward adjustment of existing warrant exercise prices to $0.10 on shareholder dilution.
- Review the full text of the Shareholder Voting Agreement to understand potential changes in corporate control.
- Monitor the progress of the semi-industrial testing with Tradepro Inc. as a potential revenue driver.
- Assess the company's remaining cash reserves given the use of proceeds for working capital and the absence of reported revenue in this filing.